Singapore: Takeda Pharmaceutical and Advinus Therapeutics jointly announced that they would be initiating a three-year d...
Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule...
Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltr...
Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined...
Singapore: Israel-based Compugen and global pharmaceutical company Bayer are to jointly pursue a preclinical research pr...
Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combina...
Singapore: Genentech, a member of the Roche Group, has recieved US FDA approval for Perjeta (pertuzumab) regimen for neo...
Singapore: The US Food and Drug Administration (FDA) has issued a complete response letter to Janssen Therapeutics for ...
Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, rec...
Singapore: Demonstrating its commitment to clinical trial transparency, multinational pharmaceutical company GlaxoSmithK...
Singapore: Taiwan's PharmaEngine appointed Dr Alain Herrera as senior advisor for clinical strategy, operations, corpora...
Singapore: A team of American and Chinese neuroscientists at the Cold Spring Harbor Laboratory (CSHL) have carried out r...
Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operati...
Singapore: Helmedix, an early stage biopharmaceutical company developing novel therapies for autoimmune and inflammatory...
Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief fi...
Singapore: Novartis entered into an exclusive global licensing and research collaboration agreement with Regenerex, a bi...
Singapore: The shareholders of Boehringer Ingelheim have appointed Dr Joachim Hasenmaier to Boehringer Ingelheim's board...
Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine ta...
